Literature DB >> 15246717

Safety and efficacy of rosuvastatin.

Gunnar O Olsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15246717     DOI： 10.1016/S0140-6736(04)16616-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Association of Rosuvastatin Use with Risk of Hematuria and Proteinuria.

Authors:  Jung-Im Shin; Derek M Fine; Yingying Sang; Aditya Surapaneni; Stephan C Dunning; Lesley A Inker; Thomas D Nolin; Alex R Chang; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2022-07-19       Impact factor: 14.978

2.  A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.

Authors:  Keith B Hoffman; Christina Kraus; Mo Dimbil; Beatrice A Golomb
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

3.  Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting system.

Authors:  Toshiyuki Sakaeda; Kaori Kadoyama; Yasushi Okuno
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.